Social Prescribing
Social Prescribing (Community Referral, Link Worker Model)
Evidence grade varies by use. See the breakdown on the entry. Read how the Atlas grades evidence.
Evidence is growing but mixed in quality, and the strongest signals are modest. A 2025 Lancet Public Health analysis of the England national rollout (reported as 4.1 million respondents, 1,268 primary care networks, 2018-2023) reported small but positive associations: improved patient experience of general practice, better confidence managing long-term conditions, and patients with mental-health needs more likely to feel understood, but no significant association with reduced social isolation, and the design was repeated cross-sectional rather than longitudinal. Earlier systematic reviews were blunter: a widely cited 2017 review ("less rhetoric and more reality") and a 2022 NIHR-funded rapid review found very few randomized controlled trials (the NIHR review reportedly identified only one RCT among 15 primary studies), small samples, weak comparators, and heterogeneous outcomes. Some health-economic reviews report positive social-return-on-investment estimates, but these rest on a small number of trials. The honest summary: emerging human data support benefits for patient experience, self-management confidence, and some wellbeing measures, while claims of reduced loneliness and reduced service use remain under-evidenced and inconsistent.
Reference only. Not medical advice.
| Treatment | Grade | Notes |
|---|---|---|
| Patient experience of care / feeling understood | 3 of 5 | A 2025 Lancet Public Health national-rollout analysis reported small but consistent positive associations across millions of respondents; observational design limits causal claims. |
| Self-management confidence in long-term conditions | 3 of 5 | Positive associations reported in large observational data and several smaller studies; few RCTs. |
| Wellbeing / mental wellbeing | 2 of 5 | Multiple systematic reviews report improvements but most studies are uncontrolled or low-quality; effect sizes uncertain. |
| Loneliness / social isolation | 2 of 5 | Often the stated reason for referral, yet the 2025 national analysis reported no significant reduction in isolation; review evidence is limited and mixed. |
| Reduced GP visits / emergency service use | 2 of 5 | Frequently claimed for cost savings, but high-quality controlled evidence is sparse and inconsistent; the NIHR review reportedly found one RCT overall. |
What can go wrong
Low direct physical risk. The main concerns are systemic rather than clinical: referring people to a voluntary sector that is often underfunded and unable to meet demand; widening inequity if community assets are scarce in deprived areas; and the risk of overpromising on cost savings or loneliness reduction that the evidence does not yet support. Effectiveness depends heavily on the link worker relationship and on the actual existence of accessible local activities. Because referrals frequently involve people with mental-health needs, isolation, or distress, social prescribing should sit alongside, not substitute for, appropriate clinical assessment and management.
This is something to take to a clinician. The Atlas can tell you what is known about social prescribing in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Social prescribing is a delivery model that lets primary-care clinicians refer patients to non-clinical, community-based support: a link worker meets the person, works out what matters to them, and connects them to activities like exercise groups, arts and nature programs, debt or housing advice, or befriending services. NHS England turned it into national policy through the 2019 NHS Long Term Plan, mandated it for every primary care network by 2022, and reports employing more than 3,600 link workers; the model has spread to Canada, Japan, Australia, Singapore, the Republic of Korea, and across the EU, with the World Health Organization, the International Social Prescribing Collaborative, and the National Academy for Social Prescribing publishing a joint global mapping in 2024 and a 2026 Western Pacific series. For the Enel library, social prescribing matters less as a single intervention than as the system-level scaffolding for the entire relational category: it is the formal pathway by which the social-connection evidence base reaches patients. The evidence for that scaffolding is real but still maturing, strongest for patient experience and self-management confidence, weaker and inconsistent for the loneliness and service-use claims most often used to justify it.
A health professional writes you a referral not to a drug but to a choir, a garden, a debt advisor, or a walking group, with a paid link worker to actually get you there.
How it is supposed to work
The proposed mechanism is logistical and relational, not pharmacological: a link worker spends unhurried time with a person, identifies non-medical drivers of poor health (loneliness, debt, housing, inactivity, isolation), co-creates a plan, and provides active follow-up to a community activity. Proponents describe this as addressing social determinants of health that brief clinical appointments rarely have time to reach. Further proposed mechanisms that remain less established include reductions in chronic stress through restored social connection, increased self-efficacy and sense of purpose (a goal that maps onto the Japanese concept of ikigai invoked in some Asian programs), and downstream reductions in primary-care and emergency service use. The relational quality of the link-worker contact, not merely the activity prescribed, is widely proposed as the active ingredient, though which component matters most has not been isolated in controlled trials.
What people get wrong
Often saidSocial prescribing reliably cuts GP appointments and saves the health system money.
ActuallyCost-saving and reduced-service-use claims rest on a small number of trials and inconsistent results; high-quality controlled evidence is still sparse.
Often saidIt is a proven cure for loneliness.
ActuallyLoneliness is the most common referral reason, yet the 2025 England national analysis reported no significant reduction in social isolation; review evidence is mixed.
Who profits, and who pushes back
National Academy for Social Prescribing (NASP)
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Link workers give people time to focus on what matters to them and connect them to community support that medicine alone cannot provide.
Dr Sam Everington
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Much of what affects health is social, and a prescription to a community activity can reach what a ten-minute appointment cannot.
Authors, 2025 Lancet Public Health national-rollout analysis
Associations with patient experience and self-management were positive but small, and we found no significant association with reduced social isolation.
Authors, NIHR-funded rapid review (2022) and '2017 less rhetoric, more reality' review
The evidence base remains thin, with very few randomized trials, weak comparators, and inconsistent outcomes; enthusiasm has outpaced robust testing.
Where the research comes from
Most of the published research on this comes from one place. 95% of it is from United Kingdom. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| United Kingdom | 95% |
| Western Pacific (Japan, Australia, Singapore, South Korea) | 55% |
| European Union | 50% |
| Canada | 45% |
| United States | 30% |
How we got here
The practice of routing people from a clinic to community resources through a trusted intermediary long predates the British branding. China's "barefoot doctors," trained from 1965 and folded into national policy by 1968, embedded roughly a million rural health workers who treated minor illness while connecting villagers to sanitation, nutrition, and collective social supports, an early state-scale model of non-clinical health navigation. Latin American promotoras and community health workers across the 20th century, and Indigenous community connectors in the Americas and the Pacific, performed the same bridging role between formal medicine and the social conditions that drive illness. The specific term "social prescribing" and the salaried "link worker" delivery model were formalized in the United Kingdom, with the Bromley by Bow Centre in East London (founded 1984, with a GP practice added in 1997 under Dr Sam Everington) widely cited as the first fully operational scheme. What the UK contributed was not the idea of community referral but a system-level pathway: standardized referral from primary care, a dedicated paid role, and national funding.
The system-level history runs from state-scale community health navigation in mid-20th-century China and the promotora and community-health-worker movements of Latin America and the Americas, to the UK's formalization of a salaried link-worker pathway. The Bromley by Bow Centre (1984; GP practice 1997) is the most-cited early operational scheme. Through the 1990s, randomized community link-worker projects ran in Nottingham, Manchester, and Cardiff. The term entered mainstream UK health policy in the 2000s and 2010s. The 2019 NHS Long Term Plan committed to embedding link workers in primary care; a 2022 mandate required every primary care network to provide social prescribing. International expansion accelerated through the 2020s, with WHO Western Pacific and Lancet attention in 2026 marking it as a global movement spanning 30-plus countries.
- 1965-1968China's barefoot-doctor program trains roughly a million rural health workers, an early state-scale model of non-clinical health navigation.
- 1984Bromley by Bow Centre founded in East London; widely cited as the first fully operational social prescribing scheme (GP practice added 1997).
- 2019NHS Long Term Plan commits to embedding social prescribing link workers across primary care in England.
- 2022Social prescribing becomes a formal mandate for every primary care network in England.
- 2024-2026WHO, ISPC, and NASP publish a global mapping (2024); WHO Western Pacific and Lancet release a regional series (2026), marking 30+ country adoption.
How it is understood
Social prescribing is a delivery system rather than a closed tradition, but it routinely draws on culturally specific community assets (faith groups, mutual-aid networks, Indigenous land and food practices). Proponents stress that link workers should connect people to community-owned activities rather than extract or medicalize them; critics warn that funneling cultural and voluntary-sector activities through a clinical referral system can strain unfunded community organizations expected to absorb demand.
Where scholars disagree
Whether social prescribing reduces loneliness and downstream service use, the outcomes most often cited to justify funding, is contested between proponents and independent evaluators.
Proponents and sector bodies (e.g. NASP, early scheme advocates)
By giving people time and connecting them to community activities, social prescribing reduces loneliness and lowers demand on GP and emergency services.
What it rests onPositive social-return-on-investment estimates and patient-experience and self-management gains reported in observational data and smaller studies.
Independent systematic reviewers and national-rollout evaluators (NIHR 2022 rapid review; 2025 Lancet Public Health analysis)
High-quality evidence for reduced loneliness and reduced service use is lacking; the largest national analysis found no significant reduction in social isolation.
What it rests onVery few RCTs (the NIHR review reportedly identified one among 15 primary studies), weak comparators, heterogeneous outcomes, and a null isolation finding in the 2025 repeated cross-sectional national rollout analysis.
This disagreement is live. It has not settled.
At a glance
- Delivery model
- Clinician refers to a paid link worker, who connects the person to non-clinical community activities and follows up.
- National scale
- NHS England reports embedding it via the 2019 NHS Long Term Plan; mandated for every primary care network by 2022; 3,600+ link workers in post.
- Global reach
- Active or developing in 30+ countries including Canada, Japan, Australia, Singapore, South Korea, and across the EU; WHO/ISPC/NASP joint global mapping published 2024.
- Best-evidenced outcome
- Patient experience of care and self-management confidence (small but consistent positive associations reported in 2025 national data).
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Social Prescribing. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.